The upgrade includes a transition to a fully closed system designed to strengthen process and product integrity while minimizing microbiological risk across all stages of production.
ProtaGene’s expertise in advanced protein characterization and early-stage drug product characterization is complemented by MilliporeSigma’s GMP testing capabilities and global regulatory experience.
INCOG BioPharma is a global fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products. Our facility is FDA approved, Annex 1 compliant, and uses the latest technology to provide tailored manufacturing solutions. We fill into syringes, vials, and cartridges, and offer autoinjector assembly, final packaging solutions, and in-house analytics. Our experienced team creates value for customers by decreasing manufacturing times and simplifying complex supply chains, enabling drug developers to focus on advancing their therapies with confidence.
Siegfried offers contract development and manufacturing of APIs, intermediates, and finished dosage forms. From early-phase development to commercial scale, its integrated approach ensures comprehensive services, including process development, registration, production, packaging, and logistics. Siegfried operates 13 facilities in 7 countries worldwide.
